Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Amprenavir

Generic Name: Amprenavir

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₃₅N_₃O_₆S

CAS Number: 161814-49-9

Unique Ingredient Identifier: 5S0W860XNR

Overview

Amprenavir is a protease inhibitor used to treat HIV infection.

Background

Amprenavir is a protease inhibitor used to treat HIV infection.

Indication

用于高效抗逆转录病毒疗法（HAART）的组成药物。

Associated Conditions

No associated conditions information available.

Clinical Trials

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults

Phase 1

Terminated

Posted: 2014/07/08

Sponsor:Boehringer Ingelheim

ID:NCT02182765

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.

Phase 2

Completed

Posted: 2005/09/20

Sponsor:

French National Agen...

ID:NCT00196625

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Phase 4

Completed

Posted: 2005/09/19

Sponsor:Kirby Institute

ID:NCT00192660

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Phase 2

Completed

Posted: 2003/03/21

Sponsor:Boehringer Ingelheim

ID:NCT00056641

Once-Daily Drug Regimen for HIV-Infected Patients

Phase 1

Completed

Posted: 2002/12/10

Sponsor:National Institute o...

ID:NCT00001968

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy